Optum — In our previous story on this topic, we reviewed some of the basics about orphan drugs. In brief, orphan drugs are aimed at extremely rare diseases; defined as afflicting fewer than 200,000 patients in the U.S.1 Out of approximately 7,000 known rare diseases, 95% still have no approved therapies.